+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase, and Others), Product Type, Infection Type, and End User

  • PDF Icon

    Report

  • 227 Pages
  • August 2021
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5416154
The real-time PCR (qPCR) segment by type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Asia Pacific PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Product Type, Infection Type, End-user and Country.” The Asia Pacific PCR for respiratory infection diagnostics market is expected to reach US$ 1,515.94 million by 2028 from US$ 737.47 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. The report highlights trends prevailing in the Asia Pacific PCR for respiratory infection diagnostics market and the factors driving market along with those that act as hindrances. The growth of the market is determined due to some of the key driving factors, such as increasing burden of chronic respiratory diseases (CRDs) and growing developments in PCR testing, are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the market growth.

PCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of dPCR techniques. Digital PCR (dPCR) has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories. In addition, rising incidence of target infectious diseases and genetic disorders; increasing investments, funds, and grants; and growing utilization of biomarker profiling for disease diagnostics are among other factors that are likely to make PCR an indispensable tool for the future. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals for identifying influenza virus infection that causes respiratory outbreaks. Therefore, various companies are offering PCR kits that can detect the presence of pathogens causing respiratory diseases. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.

COVID-19 pandemic has widely affected the economies in the Asia Pacific region. The rising occurrence COVID-19 cases results in increased stress on the region's healthcare system, which is also rising the demand for diagnostic tests in the healthcare system, supporting the expansion of the sector in this region. Hence, countries such as India, China, and South Korea have increased their capacities to conduct PCR testing. Several manufacturers are developing advanced PCR test kits and systems for the detection of COVID-19 virus. Also, high throughput molecular testing is expected to play a central role in the future management of the COVID-19 pandemic. Thus, such developments in the market are likely to foster the growth of market during the forecast period.

The Asia Pacific PCR for respiratory infection diagnostics market, by type, is segmented into real time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. Based on product type, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. Based on infection type, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal & other pathogens. The bacterial infection segment is further divided into bordetella, streptococcus pneumoniae, staphylococcus aureus, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydophila pneumoniae, legionella and others. Additionally, the viral infection segment is further bifurcated into rhinoviruses, influenza virus, severe acute respiratory syndrome (sars) cov-2 virus, respiratory syncytial virus (rsv), adenovirus, enterovirus, parainfluenza, human metapneumovirus (hmpv) and others. Further, based on End-user, the Asia Pacific PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. Geographically, the Asia Pacific PCR for respiratory infection diagnostics market can be segmented into India, Japan, China, South Korea, Australia and Rest of Asia Pacific.

Abbott, F. HOFFMANN-LA ROCHE LTD, Hologic, Inc. BD, BIO-RAD LABORATORIES INC. bioMerieux SA, QIAGEN, Thermo Fisher Scientific Inc. and Seegene Incare among the leading companies operating in the Asia Pacific PCR for respiratory infection diagnostics market

Reasons to buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific PCR for respiratory infection diagnostics market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific PCR for respiratory infection diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific PCR for Respiratory Infection Diagnostics Market - By Type
1.3.2 Asia Pacific PCR for Respiratory Infection Diagnostics Market - By Product Type
1.3.3 Asia Pacific PCR for Respiratory Infection Diagnostics Market - By Infection Type
1.3.4 Asia Pacific PCR for Respiratory Infection Diagnostics Market - By End User
1.3.5 Asia Pacific PCR for Respiratory Infection Diagnostics Market - By Country
2. Asia Pacific PCR for Respiratory Infection Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. PCR for Respiratory Infection Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific - PEST Analysis
4.3 Experts Opinion
5. PCR for Respiratory Infection Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Burden of Chronic Respiratory Diseases (CRDs)
5.1.2 Growing Developments in PCR Testing
5.2 Market Restraints
5.2.1 Availability of Alternative Assays
5.3 Market Opportunities
5.3.1 Use of PCR Testing for Various Respiratory Infection Diagnostics
5.4 Future Trends
5.4.1 Developments in PCR Technology
5.5 Impact analysis
6. PCR for Respiratory Infection Diagnostics Market - Asia Pacific Analysis
6.1 Asia Pacific PCR for Respiratory Infection Diagnostics Market Revenue Forecast and Analysis
7. PCR for Respiratory Infection Diagnostics Market Analysis by Type
7.1 Overview
7.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Real Time PCR (qPCR)
7.3.1 Overview
7.3.2 Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multiplex PCR
7.4.1 Overview
7.4.2 Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Traditional PCR
7.5.1 Overview
7.5.2 Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Digital PCR
7.6.1 Overview
7.6.2 Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Reverse Transcriptase (RT-PCR)
7.7.1 Overview
7.7.2 Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. PCR for Respiratory Infection Diagnostics Market Analysis - By Product Type
8.1 Overview
8.2 PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
8.3 Reagents and kits
8.3.1 Overview
8.3.2 Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. PCR for Respiratory Infection Diagnostics Market - By Infection Type
9.1 Overview
9.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type, 2021 & 2028 (%)
9.3 Bacterial Infections
9.3.1 Overview
9.3.2 Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Bordetella
9.3.3.1 Overview
9.3.3.2 Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.4 Streptococcus Pneumoniae
9.3.4.1 Overview
9.3.4.2 Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.5 Staphylococcus Aureus
9.3.5.1 Overview
9.3.5.2 Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.6 Haemophilus Influenzae
9.3.6.1 Overview
9.3.6.2 Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.7 Moraxella Catarrhalis
9.3.7.1 Overview
9.3.7.2 Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.8 Mycoplasma Pneumoniae
9.3.8.1 Overview
9.3.8.2 Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.9 Chlamydophila Pneumoniae
9.3.9.1 Overview
9.3.9.2 Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.10 Legionella
9.3.10.1 Overview
9.3.10.2 Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.11 Others
9.3.11.1 Overview
9.3.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4 Viral Infection
9.4.1 Overview
9.4.2 Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Rhinoviruses
9.4.3.1 Overview
9.4.3.2 Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.4 Influenza Virus
9.4.4.1 Overview
9.4.4.2 Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.5 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
9.4.5.1 Overview
9.4.5.2 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.6 Respiratory Syncytial Virus (RSV)
9.4.6.1 Overview
9.4.6.2 Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.7 Adenovirus
9.4.7.1 Overview
9.4.7.2 Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.8 Enterovirus
9.4.8.1 Overview
9.4.8.2 Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.9 Parainfluenza
9.4.9.1 Overview
9.4.9.2 Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.10 Human Metapneumovirus (hMPV)
9.4.10.1 Overview
9.4.10.2 Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.11 Others
9.4.11.1 Overview
9.4.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5 Fungal and Other Pathogens
9.5.1 Overview
9.5.2 Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10. PCR for Respiratory Infection Diagnostics Market - By End User
10.1 Overview
10.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2021 and 2028)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4 Physician Clinics
10.4.1 Overview
10.4.2 Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5 Clinical Laboratories
10.5.1 Overview
10.5.2 Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.6 Academic and Research Institutions
10.6.1 Overview
10.6.2 Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.7 Biotech and Pharma Companies
10.7.1 Overview
10.7.2 Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11. PCR for Respiratory Infection Diagnostics Market - Asia Pacific Analysis
11.1 Asia Pacific: PCR for Respiratory Infection Diagnostics Market
11.1.1 Overview
11.1.2 Asia Pacific: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.2.1 China: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 China: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 China PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3 China PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4 China PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4.1 China PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4.2 China PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 China PCR for Respiratory Infection Diagnostics Market, By End Use - Revenue and Forecast to 2028 (USD Million)
11.1.2.2 Japan: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Japan: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Japan PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 Japan PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 Japan PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4.1 Japan PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4.2 Japan PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 Japan PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.1.2.3 India: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 India: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 India PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 India PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 India PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4.1 India PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4.2 India PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 India PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.1.2.4 South Korea: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.1 South Korea: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.2 South Korea PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.3 South Korea PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.4 South Korea PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.4.1 South Korea PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.4.2 South Korea PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.4.5 South Korea PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.1.2.5 Australia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.1 Australia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.2 Australia PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.3 Australia PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.4 Australia PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.4.1 Australia PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.4.2 Australia PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.5.5 Australia PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.1.2.6 Rest of Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.1 Rest of Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.2 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.3 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.4 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.4.1 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.4.2 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.1.2.6.5 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. PCR For Respiratory Infection Diagnostics Market-Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hologic, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BD
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 QIAGEN
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Seegene Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 AusDiagnostics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About
15.2 Glossary of Terms
List of Tables
Table 1. China PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 2. China PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 3. China PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 4. China PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 5. China PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 6. China PCR for Respiratory Infection Diagnostics Market, By End Use - Revenue and Forecast to 2028 (USD Million)
Table 7. Japan PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Japan PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Japan PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 10. Japan PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 11. Japan PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 12. Japan PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 13. India PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 14. India PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 15. India PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 16. India PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 17. India PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 18. India PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 23. South Korea PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 24. South Korea PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 25. Australia PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 26. Australia PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 27. Australia PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 28. Australia PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 29. Australia PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 30. Australia PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 37. Recent Inorganic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market
Table 38. Recent Organic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market
Table 39. Glossary of Terms, PCR for Respiratory Infection Diagnostics Market
List of Figures
Figure 1. PCR for Respiratory Infection Diagnostics Market Segmentation
Figure 2. PCR for Respiratory Infection Diagnostics Market Segmentation, By Country
Figure 3. Asia Pacific PCR for Respiratory Infection Diagnostics Market Overview
Figure 4. Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment in PCR for Respiratory Infection Diagnostics Market
Figure 5. Asia Pacific PCR for Respiratory Infection Diagnostics Market - Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 7. PCR for Respiratory Infection Diagnostics Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific PCR for Respiratory Infection Diagnostics Market - Revenue Forecast and Analysis - 2020 - 2028
Figure 9. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 10. Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
Figure 17. Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2021 & 2028 (%)
Figure 21. Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 22. Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 23. Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 24. Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 25. Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 26. Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 27. Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. PCR for Respiratory Infection Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 43. Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Asia Pacific: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 50. Asia Pacific: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 51. China: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. Japan: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. India: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. South Korea: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. Australia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD
  • Hologic, Inc.
  • BD
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Seegene Inc

Table Information